We believe a personalised approach to medicine is the key to improving health outcomes for patients. The idea behind this Personalised Medicine is that healthcare can be customised to fit the unique characteristics of each person’s disease.
Based on each individual’s genetic and molecular make up, personalised medicine recognises individual differences in the causes and progression of diseases. This approach can lead to earlier, more effective diagnosis and treatment, improved prevention strategies and improved monitoring of side-effects, which ultimately benefits the individual patient as well as the healthcare system overall.
As a biobank, we promote personalised medicine by working closely with clinicians and providing researchers with the biological samples, data and technologies they need. In Luxembourg, the organisations that are committed to personalising healthcare work together under the umbrella of the Personalised Medicine Consortium (PMC). As an initiative to foster collaborative research, the PMC regroups IBBL, the Luxembourg Institute of Health (LIH) and the Laboratoire National de Santé (LNS), as well as the Luxembourg Centre for Systems Biomedicine (LCSB) and the Life Sciences Research Unit (LSRU) of the University of Luxembourg.
Together with these partners and the Luxembourg government we have decided to make certain diseases and research areas a priority. Discover our research programmes: